header-main-logo

Faculty

Adi Diab, MD

Adi Diab, MD

Cleveland Clinic Abu Dhabi

UAE

Scientific Director, Oncology Institute, Cleveland Clinic Abu Dhabi, UAE; Affiliated Faculty, Cleveland Clinic Foundation.

Alexandra Dreyfuss, MD, MSTR

Alexandra Dreyfuss, MD, MSTR

University of Miami / Sylvester Comprehensive Cancer Center

USA

Executive Director of ILROG; leads global coordination, education, and publication of lymphoma RT guidelines.

Alison Moskowitz, MD

Alison Moskowitz, MD

Memorial Sloan Kettering Cancer Center

USA

Co-author of the NCCN Hodgkin Lymphoma Guidelines, Clinical Director of the Lymphoma Inpatient Unit at MSKCC, and Editorial Board member of Haematologica, Acta Haematologica, and JCO Oncology Advances.

Andrew Zelenetz, MD, PhD

Andrew Zelenetz, MD, PhD

Memorial Sloan Kettering Cancer Center

USA

Founding Chair of the NCCN Non-Hodgkin Lymphoma Panel and former Chief of the Lymphoma Service at MSKCC.

Areen Alzrigat, PharmD

Areen Alzrigat, PharmD

Cleveland Clinic Abu Dhabi

UAE

Bassel Jallad, MD

Bassel Jallad, MD

Cleveland Clinic Abu Dhabi

UAE

Dr. Bassel Jallad, MD, CPE is a Staff Physician within the Medical Oncology Department of Cleveland Clinic Abu Dhabi’s Cancer Institute.

Prior to joining Cleveland Clinic Abu Dhabi, Dr. Jallad was the Associate Director of Medical Oncology Fellowship Program at St Louis University in St Louis, Missouri and the Medical Director of Medical Oncology Service Line at Blessing Health System in Quincy, Illinois, USA.

Dr. Jallad received his medical degree from Jordan University of Science and Technology, Irbid, Jordan, and completed his residency at the University of Illinois, Chicago, USA. He completed his fellowship at the Henry Ford Hospital, Wayne State University, Michigan, USA. Dr. Jallad is triple American Board Certified in Internal Medicine , Medical Oncology and Hematology.

Throughout his tenure, Dr. Jallad has specialized in managing different cancer types, especially Breast Cancer, and the management of benign and malignant hematological disorders. Dr. Jallad has multiple peer reviewed publications discussing various cancer related topics in highly influential medical journals

Currently, Dr. Jallad resides in Abu Dhabi, with his wife and three children. When he is not working at Cleveland Clinic Abu Dhabi, Dr. Jallad enjoys swimming and working on his tennis skills.

Bouthaina Dabaja, MD, FASTRO

Bouthaina Dabaja, MD, FASTRO

The University of Texas MD Anderson Cancer Center

USA

Professor and Section Chief of Hematology, Division of Radiation Oncology
Professor, Department of Leukemia, Division of Cancer Medicine.
Incident Commander, Division of Radiation Oncology
University of Texas MD Anderson Cancer Center
Director of Research, International Lymphoma Radiation Oncology Group (ILROG)

Brandon Imber, MD

Brandon Imber, MD

Memorial Sloan Kettering Cancer Center

USA

Radiation oncologist and Associate Director of Education in Lymphoma RT at MSKCC; active ILROG member.

Carla Hajj, MD

Carla Hajj, MD

Cleveland Clinic Abu Dhabi

UAE

Radiation Oncologist and Director of Clinical Research at the Oncology Institute, CCAD; Editorial Board Member of Frontiers in Oncology and Hepatoma Research; active member of the NRG GI Hepatobiliary Working Group with expertise in ablative and particle therapies.

Caroline Samaha Jabbour, MD

Caroline Samaha Jabbour, MD

Mount Lebanon Hospital

Lebanon

Former chief of Radiation Oncology at Mount Lebanon Hospital, Lebanon, graduate of Saint Joseph University, active researcher in health equity and access to radiation therapy.

Dina Mouzayan, RN

Dina Mouzayan, RN

Yas Clinic Khalifa City and Abu Dhabi Stem Cells Center

UAE

Eldad Dann, MD, PhD

Eldad Dann, MD, PhD

Rambam Medical Center, Haifa

Israel

Elizabeth Spyropoulos, RN

Elizabeth Spyropoulos, RN

Cleveland Clinic Abu Dhabi

UAE

Erel Joffe, MD

Erel Joffe, MD

Tel Aviv Medical Center

Israel

Dr. Joffe is a board-certified hemato-oncologist and biomedical informatician with expertise in both clinical hematology and computational medicine. His background combines traditional clinical practice with emerging technologies in genomics and artificial intelligence.Dr. Joffe serves as the Director of Clinical Trials Service at Tel Aviv Medical Center's Division of Hemato-Oncology and Cellular Therapy, where he supports a portfolio of over 50 active clinical trials in all phases. Clinically, he is a senior attending with the Lymphoma Service at TLVMC and heads the Low-Grade B Cell Lymphomas and Primary CNS Lymphoma programs. Formerly he served as a faculty member of the Lymphoma Service at Memorial Sloan Kettering Cancer Center in New York.Dr. Joffe's research spans both clinical and computational domains, with over 50 peer-reviewed publications in journals such as Blood, Haematologica, and the JCO. He has served as principal investigator on multiple clinical trials, including several investigator-initiated studies. His bioinformatics research focuses on genome-phenotype association studies and developing artificial intelligence and machine learning applications.Lastly, in addition to his clinical and research work, Dr. Joffe leads a small non-profit organization that provides lymphoma patients with evidence-based guidance and facilitates enrollment on relevant clinical trials (>5000 members).

Fady Geara, MD, PhD

Fady Geara, MD, PhD

Cleveland Clinic Abu Dhabi

UAE

Chair of Radiation Oncology at the Fatima Bint Mubarak Center, Cleveland Clinic Abu Dhabi, UAE.

Farah Farroukh, RN

Farah Farroukh, RN

Cleveland Clinic Abu Dhabi

UAE

Fatin Sammour, MD

Fatin Sammour, MD

Cleveland Clinic Abu Dhabi

UAE

Staff Physician in Medical Oncology & Hematology at CCAD with extensive UK and UAE experience in leukemia, lymphoma, and myeloma care.

George Mikhaeel, MD

George Mikhaeel, MD

Guy's & St Thomas' NHS Foundation Trust

UK

Consultant Radiation Oncologist and ILROG Steering Committee member; expert in imaging-adaptive RT at Guy's and St Thomas'.

Hamza Hashmi, MD

Hamza Hashmi, MD

Memorial Sloan Kettering Cancer Center

USA

Assistant Attending, Myeloma & Cell Therapy Service, Memorial Sloan Kettering Cancer Center <br>Assistant Professor of Medicine.

Hans Theodor Eich, MD, PhD

Hans Theodor Eich, MD, PhD

University of Münster

Germany

Issam Maita, RN

Issam Maita, RN

Cleveland Clinic Abu Dhabi

UAE

Joachim Yahalom, MD

Joachim Yahalom, MD

Memorial Sloan Kettering Cancer Center

USA

Founding Chair of ILROG and Director of Radiation Oncology for Lymphoma at MSKCC; global authority on lymphoma RT guidelines.

Juliet George Teddy, MD

Juliet George Teddy, MD

Abu Dhabi Biobank

UAE

Julieta Osorio Zuluaga, MD

Julieta Osorio Zuluaga, MD

American Hospital Dubai

UAE

Consultant Hematologist, American Hospital Dubai.

Lena Specht, MD

Lena Specht, MD

Copenhagen University Hospital

Denmark

Chair of Oncology and Director of the Lymphoma RT Program at Rigshospitalet, University of Copenhagen; ILROG founding member.

Louis "Sandy" Constine, MD

Louis "Sandy" Constine, MD

University of Rochester and Wilmot Cancer Institute

USA

Senior Radiation Oncologist at the University of Rochester and Wilmot Cancer Institute. He is internationally recognized for his work in pediatric cancers, lymphomas, and survivorship, and serves on NCCN guideline panels. He is also on the editorial boards of the International Journal of Radiation Oncology • Biology • Physics and the Journal of Adolescent and Young Adult Oncology, shaping advances in cancer care worldwide.

Miriam Adelson, MD

Miriam Adelson, MD

Adelson Clinic for Drug Abuse Treatment and Research

Mohamed Abuhaleeqa, MD

Mohamed Abuhaleeqa, MD

Abu Dhabi Stem Cells Center

UAE

Consultant Hematologist & Bone Marrow Transplant Specialist; Chair of Academic Affairs, Abu Dhabi Stem Cells Center (ADSCC).

Paolo Caimi, MD

Paolo Caimi, MD

Cleveland Clinic Foundation

USA

Associate Professor at Case Western Reserve University, Associate Director of Cellular Therapy at Cleveland Clinic, and lymphoma expert leading clinical trials in CAR T-cell therapy, stem cell transplantation, and novel immunotherapies.

Paul Ramia, MD, FRCP

Paul Ramia, MD, FRCP

Cleveland Clinic Abu Dhabi

UAE

Consultant Radiation Oncologist, Cleveland Clinic Abu Dhabi.

Rachael Almond, PhD

Rachael Almond, PhD

Abu Dhabi Biobank

UAE

Rehab Al-Blooshi, MD

Rehab Al-Blooshi, MD

University Hospital Sharjah

UAE

Consultant Hematologist & Medical Director, Cord & Blood Research Centre; Stem Cell Transplant Specialist, University Hospital Sharjah.

Rhodora Manville, RN

Rhodora Manville, RN

Cleveland Clinic Abu Dhabi

UAE

Roni Shouval, MD, PhD

Roni Shouval, MD, PhD

Memorial Sloan Kettering Cancer Center

USA

Director, Precision Cellular Therapy Laboratory
Assistant Attending
.Adult BMT Service
Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Sara Saad, PharmD

Sara Saad, PharmD

Cleveland Clinic Abu Dhabi

UAE

Serra Kamer, MD

Serra Kamer, MD

Ege University, Izmir

Turkey

Professor of Radiation Oncology at Ege University Faculty of Medicine, İzmir Fellowship in Radiosurgery and Conformal Radiotherapy at Vrije University, Netherlands Fellowship in IMRT techniques at Rambam Hospital, Israel (Middle East Cancer Consortium Grant) Research Fellow in Radiobiology at Thomas Jefferson University, USA

Shahrukh Hashmi, MD

Shahrukh Hashmi, MD

Department of Health, Abu Dhabi

UAE

Global key opinion leader in the field of cancer, stem cells and Artificial Intelligence, Prof. Shahrukh Hashmi currently directs the Research at the Department of Health, Abu Dhabi, UAE; he practices as a professor of medicine at the Mayo Clinic (Minnesota, US) and is a professor (adjunct) of Computer Vision at MBZ-University of Artificial Intelligence (Abu Dhabi, UAE).

Shunan Qi, MD

Shunan Qi, MD

Chinese Academy of Medical Sciences & Peking Union Medical College

China

Stephen R. Grobmyer, MD

Stephen R. Grobmyer, MD

Cleveland Clinic Abu Dhabi

UAE

Steven Horwitz, MD

Steven Horwitz, MD

Memorial Sloan Kettering Cancer Center

USA

Member and Attending Physician at Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Suhendan Ekmekcioglu, PhD

Suhendan Ekmekcioglu, PhD

Cleveland Clinic Abu Dhabi

UAE

Tahani Dweikat, RN, ANT

Tahani Dweikat, RN, ANT

City of Hope National Medical Center

USA

Venkada Manickam, MD

Venkada Manickam, MD

National Centre for Cancer Care & Research

Qatar

Specialist in Radiation Oncology at Hamad Medical Corporation, Qatar (since January 2020) Registrar in Radiation Oncology at Max Cancer Centre, New Delhi, India (2012–2020) Senior Resident at Rajiv Gandhi Cancer Institute & Research Centre, Delhi (2010–2011)

Yaser Alkhatib, MD

Yaser Alkhatib, MD

Cleveland Clinic Abu Dhabi

UAE

Consultant Medical Oncologist at Burjeel Day Surgery Center, Al Reem Island, UAE Internal Medicine and Hematology/Oncology at Henry Ford Hospital/Wayne State University, where he served as Chief Fellow Assistant Professor at MD Anderson Cancer Center, Houston, Texas

Yinon Ben Neriah, MD

Yinon Ben Neriah, MD

Hebrew University of Jerusalem

Israel

Yinon Ben-Neriah, MD-PhD, is a professor of immunology and cancer research at the Hebrew University of Jerusalem. He is a member of the Israel Academy of Sciences and Humanities, an EMBO member, elected fellow of the European Academy of Cancer Sciences and recipient of the Israel Prize for Medical Research. Yinon studies cancer development and therapy and among his achievements are the developent of a first prototype inhibitor of the CML oncoprotein Bcr-Abl; deciphering key components in the NF-B and Wnt signaling pathway; identifying NF-B as the first molecular link between inflammation and cancer; elucidating mechanisms for WNT and mutant p53 activation and developing a new class of small molecule kinase inhibitors with profound therapeutic effects in preclinical and early clinical studies in several cancer types.

Zeina Kassem, RN

Zeina Kassem, RN

Cleveland Clinic Abu Dhabi

UAE

ACCME Accreditation Statement

Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ACCME Credit Designation Statement

Cleveland Clinic Abu Dhabi designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits TM

Physicians should obtain only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST

The planning committee, faculty, and others in control of content (either individually or as a group) have disclosed relevant financial relationships with ineligible companies. All relevant financial relationships have been reviewed and mitigated in accordance with ACCME standards.

lymphomaconferencesecretary@wearemci.com

Send a Email

+971 4 311 6300

Any Time Call Us

Cleveland Clinic Abu Dhabi, UAE

Our Address
TOP